∗University Lille, CHU Lille, INSERM, Oral and Maxillofacial Surgery Department, U 1008–Controlled Drug Delivery Systems and Biomaterials, Lille
†University d’Auvergne, CHU Clermont-Ferrand, Oral and Maxillofacial Surgery Department, Clermont-Ferrand
‡INSERM, U 1008–Controlled Drug Delivery Systems and Biomaterials
§Oral and Maxillofacial Surgery Department, CHU Lille, University Lille, Lille, France
||Ear Nose and Throat Department, Al Nahdha Hospital, Oman.
Address correspondence and reprint requests to Matthias Schlund, MD, MSc, Service de Chirurgie Maxillo-Faciale et Stomatologie, Hôpital Roger Salengro, Rue Emile Laine, 59037-Lille-Cedex, France; E-mail: [email protected]
Received 9 March, 2019
Accepted 17 August, 2019
The authors report no conflicts of interest.